The price of these hep C drugs in dropping due to competition.
When Gilead came out with theirs, they thought they had a monopoly and could charge anything they liked. Then AbbVie came out with one and got a big contract by offering a deal. Once a third one comes along, the pressure to cut the prices will be enormous.
Agreed. An this competition is ultimately good for consumers as well as the pharmaceutical companies.